Renata’s profit jumps 64% as finance costs fall

Renata PLC, a listed pharmaceutical company, staged a profit turnaround in fiscal year 2025-26 (FY26), with annual profit rising 64 percent and revenue growing at a more modest pace.

The company’s revenue increased 7.7 percent year-on-year to BDT 46.20bn, while its profit rose to BDT 3.64bn, recovering from a 44 percent decline in FY25 when high finance costs linked to investments in a new plant weighed on earnings.

The improvement came mainly from higher sales volumes, particularly in the domestic pharmaceutical market, better procurement, improved operational efficiency and lower finance costs following capital restructuring.

https://www.thedailystar.net/business/economy/news/renatas-profit-jumps-64-finance-costs-fall-4301236